The first-in-human trial for tebentafusp findings are in, and they show promise for managing a patients side effects to it.
Alexander N. Shoushtari, MD
Advertisement
Articles by Alexander N. Shoushtari, MD
Advertisement
Latest Updated Articles
First-in-Human Trial for Tebentafusp In Advanced Melanoma Shows Promising Safety ProfilePublished: November 27th 2019 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Intensified First-Line Therapy for dMMR/MSI-H mCRC: Nursing Implications of the COMMIT Trial
2
15,000 NYC Nurses Strike Highlights Impact on Oncology Care
3
Adjuvant ChemoRT Yields Long-Term Survival in High-Risk Endometrial Cancer
4
JSKN003 Given FDA Breakthrough Therapy Status in HER2+ PROC
5